Evidence map›Paper›PMID 31441604›Full record

ArticleObesity (Silver Spring, Md.)2019

Cardioprotective Heme Oxygenase-1-PGC1α Signaling in Epicardial Fat Attenuates Cardiovascular Risk in Humans as in Obese Mice.

Shailendra P Singh, John A McClung, Ellen Thompson, Yosef Glick, Menachem Greenberg, Giancarlo Acosta-Baez, Basel Edris, Joseph I Shapiro, Nader G Abraham

Open access · hybridAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Epicardial Adipocytes in Cardiac Pathology and Healing.Cardiovascular drugs and therapy · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. RETRACTED: Cold-PressedAntioxidants (Basel, Switzerland) · 2020
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shailendra P SinghDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.
John A McClungDepartment of Medicine, New York Medical College, Valhalla, New York, USA.
Ellen ThompsonDepartment of Cardiology, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA.
Yosef GlickDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.
Menachem GreenbergDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.
Giancarlo Acosta-BaezDepartment of Cardiology, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA.
Basel EdrisDepartment of Cardiology, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA.
Joseph I ShapiroDepartment of Internal Medicine, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA.
Nader G AbrahamDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.ORCID 0000-0001-8983-1959
New York Medical College · USMarshall University · US

Funding

Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac DiseasesR01HL109015 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SHAPIRO, JOSEPH ISAAC, XIE, ZIJIAN · 2011 to 2014
$2.2M
Adipocyte EET-PGC1alpha-HO-1 in Obesity-driven HypertensionR56HL139561 · NHLBI · NEW YORK MEDICAL COLLEGE · PI ABRAHAM, NADER G. · 2018 to 2018
$503k
NHLBI NIH HHS R01 HL109015NHLBI NIH HHS R56 HL139561
6 · The paper itself

Abstract

objectiveThis study investigated whether levels of signaling pathways and inflammatory adipokines in epicardial fat regulate cardiovascular risks in humans and mice.

methodsEpicardial fat was obtained from the hearts of patients with heart failure requiring coronary artery bypass surgery, and signaling pathways were compared with visceral fat. The genetic profile of epicardial and visceral fat from humans was also compared with genetic profiles of epicardial and visceral fat in obese mice. Left ventricular (LV) fractional shortening was measured in obese mice before and after treatment with inducers of mitochondrial signaling heme oxygenase 1 (HO-1)-peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α). An RNA array/heat map on 88 genes that regulate adipose tissue function was used to identify a target gene network.

resultsHuman epicardial fat gene profiling showed decreased levels of mitochondrial signaling of HO-1-PGC1α and increased levels of the inflammatory adipokine CCN family member 3. Similar observations were seen in epicardial and visceral fat of obese mice. Improvement in LV function was linked to the increase in mitochondrial signaling in epicardial fat of obese mice.

conclusionsThere is a link between cardiac ectopic fat deposition and cardiac function in humans that is similar to that which is described in obese mice. An increase of mitochondrial signaling pathway gene expression in epicardial fat attenuates cardiometabolic dysfunction and LV fractional shortening in obese mice.

Indexed as

Adipose TissueAgedAnimalsCardiovascular DiseasesCytoprotectionFemaleHeme Oxygenase-1HumansIntra-Abdominal FatMaleMiceMice, Inbred C57BLMice, ObeseMiddle AgedMyocardiumObesityHeme Oxygenase-1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, human

Identifiers

PMID31441604
PMCPMC6756945
OpenAlexW2969545030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.